Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

A glutamate modulator improves schizophrenia-related dysfunction, may open new treatment paths

UNIVERSITY OF PITTSBURGH, AUG 12 – Evenamide, a glutamate modulator, reduced hyperactive dopamine neurons in a rat model and shows promise for treating multiple schizophrenia symptoms, affecting 1% of the global population.

Summary by Medical Xpress
New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a potential treatment for schizophrenia.

2 Articles

Medical XpressMedical Xpress
Center

A glutamate modulator improves schizophrenia-related dysfunction, may open new treatment paths

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a potential treatment for schizophrenia.

Read Full Article
New AtlasNew Atlas

New schizophrenia drug improves symptoms current drugs can’t touch

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that current antipsychotics can’t touch.Continue ReadingCategory: Body & MindTags: Schizophrenia, Medication, clinical trials, Signs and symptoms

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Monday, August 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups icon

Startups

Medical icon

Medical

News
For You
SearchBlindspotLocal